Orphan Drugs- Development Trends and Strategies

An orphan drug can be determined as one that is used to handle an orphan disease. For example, haem arginate, used to control small cintermittent porphyria, variegate porphyria, and hereditary coproporphyria is an orphan drug. A medicinal product which is came into the source as orphan drug is one that has been developed especially to treat a rare medical condition which is found, the condition itself being referred to as “orphan disease.” It may be defined as drugs that are not evolved by the pharmaceutical industry for economic reasons but which respond to public.

  • Acute intermittent porphyria
  • Variegate porphyria

Related Conference of Orphan Drugs- Development Trends and Strategies

March 18-19, 2024

20th International Conference on Cancer Research

Zurich, Switzerland
April 24-25, 2024

33rd Neonatology and Primary Care Congress

Paris, France
April 30-30, 2024

14th International Conference on Womens Health and Cancer Cure

Amsterdam, Netherlands
July 25-26, 2024

20th World Summit on Blockchain Technology

Amsterdam, Netherlands
August 20-21, 2024

11th World Summit on Epilepsy and Bipolar Disorders

Montreal, Canada

Orphan Drugs- Development Trends and Strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in